![rqm+_live_81_knowledge_center-min](https://resources.rqmplus.com/hs-fs/hubfs/RQM%20Live/Show%2081/rqm%2B_live_81_knowledge_center-min.png?width=585&height=329&name=rqm%2B_live_81_knowledge_center-min.png)
Available on demand.
RQM+ welcomes Michelle Tarver, M.D., Ph.D., Acting CDRH Director and Deputy Center Director for Transformation, FDA, CDRH, to a presentation and panel discussion aimed at increasing awareness and understanding of equity in the medical device and IVD space.
Objectives:
- Regulatory Expectations
Examining health equity concerns, regulatory efforts to promote equity, and FDA requirements for enhancing diversity in clinical trials
- Healthcare at Home
Exploring the "Home as a Healthcare Hub" initiative and its implications for health equity, including the challenges and opportunities of integrating healthcare services at home
- Industry Perspectives
Providing insights from industry leaders on how medical device companies are addressing health equity, with a focus on real-world examples and action plans
- Action Plans and Strategies
Sharing best practices for developing and implementing plans that assess diversity, explore risks, and identify actions to address health equity within medical device companies
- Interactive Q&A
Offering an opportunity for participants to engage with experts, ask questions, and gain a deeper understanding of the topic
Complete the form on this page to watch the recording and download the slides.
Panelists:
- Michelle Tarver, M.D., Ph.D. – Acting Director and Deputy Center Director for Transformation, FDA, CDRH
- Allison Komiyama, Ph.D., RAC – Vice President, MedTech Innovations, RQM+
- Jon Gimbel, Ph.D. – Vice President of Technical, RQM+
- Brandy Chittester – Senior Director, Clinical Operations, RQM+
- Jaishankar (Jai) Kutty, Ph.D. – Vice President, Global Regulatory Affairs, RQM+ (moderator)
Certificate of Participation available upon request for live attendees.